209 related articles for article (PubMed ID: 26338968)
21. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.
Mossé YP; Voss SD; Lim MS; Rolland D; Minard CG; Fox E; Adamson P; Wilner K; Blaney SM; Weigel BJ
J Clin Oncol; 2017 Oct; 35(28):3215-3221. PubMed ID: 28787259
[TBL] [Abstract][Full Text] [Related]
22. The emerging role of CD30 and p53 as novel targets for therapy in anaplastic large cell lymphoma.
Rassidakis GZ; Drakos E
Front Biosci (Elite Ed); 2016 Jan; 8(1):61-71. PubMed ID: 26709646
[TBL] [Abstract][Full Text] [Related]
23. Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines.
You L; Shou J; Deng D; Jiang L; Jing Z; Yao J; Li H; Xie J; Wang Z; Pan Q; Pan H; Huang W; Han W
Oncotarget; 2015 Nov; 6(37):40268-82. PubMed ID: 26384345
[TBL] [Abstract][Full Text] [Related]
24. EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect.
Sahnane N; Frattini M; Bernasconi B; Zappa F; Schiavone G; Wannesson L; Antonelli P; Balzarini P; Sessa F; Mazzucchelli L; Tibiletti MG; Martin V
Clin Lung Cancer; 2016 Jan; 17(1):56-61. PubMed ID: 26381283
[TBL] [Abstract][Full Text] [Related]
25. Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?
Toyokawa G; Seto T; Takenoyama M; Ichinose Y
Cancer Metastasis Rev; 2015 Dec; 34(4):797-805. PubMed ID: 26342831
[TBL] [Abstract][Full Text] [Related]
26. High Levels of miR-7-5p Potentiate Crizotinib-Induced Cytokilling and Autophagic Flux by Targeting RAF1 in NPM-ALK Positive Lymphoma Cells.
Sorrentino D; Frentzel J; Mitou G; Blasco RB; Torossian A; Hoareau-Aveilla C; Pighi C; Farcé M; Meggetto F; Manenti S; Espinos E; Chiarle R; Giuriato S
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066037
[TBL] [Abstract][Full Text] [Related]
27. A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation.
Kawasoe K; Watanabe T; Yoshida-Sakai N; Yamamoto Y; Kurahashi Y; Kidoguchi K; Ureshino H; Kamachi K; Fukuda-Kurahashi Y; Kimura S
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894456
[TBL] [Abstract][Full Text] [Related]
28. Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2
Courdy C; Platteeuw L; Ducau C; De Araujo I; Boet E; Sahal A; Saland E; Edmond V; Tavitian S; Bertoli S; Cougoul P; Granat F; Poillet L; Marty C; Plo I; Sarry JE; Manenti S; Mansat-De Mas V; Joffre C
Blood Cancer J; 2023 Jul; 13(1):106. PubMed ID: 37423955
[TBL] [Abstract][Full Text] [Related]
29. Antimalarial Activity of Tri- and Tetra-Substituted Anilino Pyrazoles.
Lusardi M; Basilico N; Rotolo C; Parapini S; Spallarossa A
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838701
[TBL] [Abstract][Full Text] [Related]
30. Autophagy in Hematological Malignancies.
García Ruiz O; Sánchez-Maldonado JM; López-Nevot MÁ; García P; Macauda A; Hernández-Mohedo F; González-Sierra PA; Martínez-Bueno M; Pérez E; Reyes-Zurita FJ; Campa D; Canzian F; Jurado M; Rodríguez-Sevilla JJ; Sainz J
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291856
[TBL] [Abstract][Full Text] [Related]
31. Nuclear ingression of cytoplasmic bodies accompanies a boost in autophagy.
Garcia M; Kumanski S; Elías-Villalobos A; Cazevieille C; Soulet C; Moriel-Carretero M
Life Sci Alliance; 2022 Sep; 5(9):. PubMed ID: 35568434
[TBL] [Abstract][Full Text] [Related]
32. Protective autophagy decreases lorlatinib cytotoxicity through Foxo3a-dependent inhibition of apoptosis in NSCLC.
Lu C; Yu R; Zhang C; Lin C; Dou Y; Wu D; Pan Y; Peng T; Tang H; Han R; He Y
Cell Death Discov; 2022 Apr; 8(1):221. PubMed ID: 35459209
[TBL] [Abstract][Full Text] [Related]
33. Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma.
Wang Y; He J; Xu M; Xue Q; Zhu C; Liu J; Zhang Y; Shi W
Front Oncol; 2022; 12():815654. PubMed ID: 35211406
[TBL] [Abstract][Full Text] [Related]
34. Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL.
Hare L; Burke GAA; Turner SD
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885113
[TBL] [Abstract][Full Text] [Related]
35. The Dual Role of Autophagy in Crizotinib-Treated ALK
Espinos E; Lai R; Giuriato S
Cells; 2021 Sep; 10(10):. PubMed ID: 34685497
[TBL] [Abstract][Full Text] [Related]
36. Heterocyclic Compounds: Pharmacology of Pyrazole Analogs From Rational Structural Considerations.
Costa RF; Turones LC; Cavalcante KVN; Rosa Júnior IA; Xavier CH; Rosseto LP; Napolitano HB; Castro PFDS; Neto MLF; Galvão GM; Menegatti R; Pedrino GR; Costa EA; Martins JLR; Fajemiroye JO
Front Pharmacol; 2021; 12():666725. PubMed ID: 34040529
[TBL] [Abstract][Full Text] [Related]
37. ALK inhibition activates LC3B-independent, protective autophagy in EML4-ALK positive lung cancer cells.
Schläfli AM; Tokarchuk I; Parejo S; Jutzi S; Berezowska S; Engedal N; Tschan MP
Sci Rep; 2021 Apr; 11(1):9011. PubMed ID: 33907223
[TBL] [Abstract][Full Text] [Related]
38. Crizotinib Resistance Mediated by Autophagy Is Higher in the Stem-Like Cell Subset in ALK-Positive Anaplastic Large Cell Lymphoma, and This Effect Is MYC-Dependent.
Shang C; Hassan B; Haque M; Song Y; Li J; Liu D; Lipke E; Chen W; Giuriato S; Lai R
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430343
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Beclin 1-Mediated Autophagy by Oncogenic Tyrosine Kinases.
Vega-Rubín-de-Celis S; Kinch L; Peña-Llopis S
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287140
[TBL] [Abstract][Full Text] [Related]
40. ALK-transformed mature T lymphocytes restore early thymus progenitor features.
Congras A; Hoareau-Aveilla C; Caillet N; Tosolini M; Villarese P; Cieslak A; Rodriguez L; Asnafi V; Macintyre E; Egger G; Brousset P; Lamant L; Meggetto F
J Clin Invest; 2020 Dec; 130(12):6395-6408. PubMed ID: 33141118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
